× Prevention of kidney injury after myocardial ischemia reperfusion is achievable with short-term protein restriction

× Sodium-glucose co-transporter 2 inhibitors (SGLT2i); as a preventive factor of kidney failure in patients with type 2 diabetes; a meta-analysis of randomized controlled trials

× Ameliorative impact of sodium–glucose cotransporter-2 inhibitors in diabetic kidney disease; a mini- review to current evidence

× Possible amelioration impact of sodium-glucose cotransporter 2 inhibitors on cisplatin-induced renal toxicity; a mini-review on recent findings

× The effect of empagliflozin on cardiovascular outcomes in patients with chronic kidney disease; a systematic review and meta-analysis

× Investigating the association between the administration of SGLT-2 inhibitors and the risk of urinary tract infection; a systematic review and meta-analysis

× Effect of sodium-glucose transporter 2 inhibitors on the risk of contrast-induced acute kidney injury; a systematic review and meta-analysis

× Emerging trends in renoprotective agents; a pharmacological perspective for world kidney day 2025